ACE and Parkinson disease: Some components of RAS have been found to be altered in Parkinson’s disease (PD) patients: ACE activity was increased in the cerebrospinal fluid and AT1R expression was decreased in the brain in a post-mortem study, which was associated with the loss of dopaminergic neurons [5, 6].